In this study, zebrafish exposed to a high-glucose treatment for 8 weeks exhibited symptoms related to T2DM, including impaired glucose tolerance and a significant decrease in skeletal muscle insulin levels (since the blood volume of zebrafish is too small to detect serum insulin levels). The gene discussed is INS; the disease is Impaired glucose tolerance.